Eli Lilly & Co. vs. Xeris Biopharma Holdings, Inc. Common Stock
LLY
Eli Lilly & Co.
$1364.73 -3.76%
VS XERSXeris Biopharma Holdings, Inc. Common Stock
$10.20 -6.08%
Eli Lilly & Co. and Xeris Biopharma Holdings, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| LLY | XERS | |
|---|---|---|
| Market Cap | $1.26 trillion | $1.98 billion |
LLY leads on 1 of 1 size & scale factors.
Dividend
| LLY | XERS | |
|---|---|---|
| Dividend Yield | 0.51% | — |
LLY and XERS split the dividend factors evenly.
Risk & Sentiment
| LLY | XERS | |
|---|---|---|
| Short Interest | 1.29% | 0.10% |
XERS leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, XERS overview, XERS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.